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Background: Haemorrhagic shock is a major cause of morbidity and mortality worldwide.  Trauma 
and its complications account for one in ten deaths worldwide and are the leading cause of death in 
those below 45 years of age in developed countries.  Survival of the shocked patient is influenced by 
the speed and efficiency with which resuscitation is carried out.  Rapid infusion of a small volume of 
7.5% hypertonic saline (HSS) has been shown to result in immediate restoration of circulating volume 
and tissue perfusion but results of investigation of its use remain inconclusive. The objective of this 
study was to determine the clinical outcomes of infusing locally made 7.5% HSS in patients with 
haemorrhagic shock.                                                                                                                           
Methods: During a six-month period, all adult trauma patients coming to the casualty with 
haemorrhagic shock were enrolled into the study.  A detailed clinical assessment was performed, and 
respiratory and cardiovascular vital signs were recorded.  Five millilitres of venous blood was drawn 
for determination of Haematocrit, haemoglobin, serum electrolytes and creatinine.  A rapid infusion 
of 250mls of HSS was given intravenously followed three to five minutes later by recording the vital 
signs again and drawing another 5 mls of blood for a repeat of the laboratory tests.  Recovery from 
shock was followed by standard fluid infusion.  Additional or alternative resuscitation and other 
therapeutic measures were taken as indicated.  Recording of the vital signs was continued at four 
hourly intervals for 24 hours. The data were entered into a computer data base and analysed.                                                                                                                
Results: Forty five patients were enrolled and resuscitated with 250 mls 7.5% HSS.  Among the 
studied patients, 88.9% recovered from shock immediately after being infused with 7.5% HSS.  Of 
patients with a single injury, 96.6% recovered from shock whereas only 75% of those with multiple 
injuries recovered. Eighty percent of patients survived beyond 24 hours post resuscitation. While 
93.1% of patients with a single injury survived beyond 24 hours, only 56.3% of those who sustained 
multiple injuries did so.                                                                  
Conclusion: Rapid resuscitation with HSS has demonstrated clinical benefits in initial treatment of 
traumatic hemorrhagic shock in patients admitted to the emergency room.  Further investigation of 
the effects of HSS resuscitation is warranted.  
Introduction  
The earliest use of hypertonic saline solution 
(HSS) for patient resuscitation was described 
some 25 years ago.  Interestingly, current use of 
HSS was initiated by a nursing error when a 
Brazillian nurse inadvertently gave an 
unconscious shocked dialysis patient 100mls of 
7.5% saline, whereupon a minute later the patient 
regained consciousness and a normal blood 
pressure1.  Subsequently experimental2,3 and 
clinical research 4,5,6,7,8 work has led to acceptance 
of the use of HSS for resuscitation in clinical 
practice 9,10. Hypovolemic shock resulting from 
haemorrhage is a major cause of morbidity and 
mortality worldwide.  Trauma and its sequelae 
account for 10% of global mortality and are the 
principal causes of death in those below 45 years 
of age in developed countries11.  A study of 
trauma deaths in a large North American city 
revealed that 60.5% of all deaths occurred before 
victims were hospitalized 12.  It has also been 
shown that exsanguination is the cause of death in 
31 to 39% of trauma deaths, and the proportion is 
higher if the complications of haemorrhagic shock 
are included 11,12.  In developing countries 
gynaecologic and obstetric bleeding is still a 
common cause of hypovolemic shock 9.   
The approach to a hypovolemic patient aims at 
prompt diagnosis of the presence of shock and its 
aetiology, rapid restoration of tissue perfusion and 
prevention of end organ failure 13,14.  After 
securing the airway and excluding any life-
threatening conditions, standard initial treatment 
requires fluid replacement with crystalloids or 
colloids. The amount infused depends on the 




intravascular volume by approximately the 
estimated blood loss. Different types of fluids 
expand the intravascular volume differently 14,15.  
An infusion of 1000mls of Ringer’s lactate (RL) 
or normal saline in an adult, for instance, (NS) 
expands the intravascular volume by 
approximately 250 millilitres within one hour 
after injection.  Five hundred milliliters of 
Dextran 70 expands the intravascular volume by 
500mls.  Five hundred milliliters of 6% 
Hetastarch expands the intravascular volume by 
approximately 800 mls in one hour and is 
sustained for at least 8 hours.  Rapid infusion of 
250mls of HSS expands the intravascular volume 
by approximately 750 to 1000mls in 2-5 minutes, 
sustained for at least 30 minutes.   
The hypoxia of hypovolemic shock leads to 
endothelial and erythrocyte oedema, capillary 
narrowing and impaired blood flow, tissue 
ischaemia and cell death 16,17.    Mobilization of 
water from the intracellular compartment has a 
double advantage: increasing plasma volume and 
increasing vascular luminal diameter.  Infusion of 
4mls/kg of HSS within 2 -5 minutes leads to 
hyperosmolality of the extracellular fluid 
compartment and mobilization of intracellular 
water into the extracellular space by osmosis of 
up to four times the infused volume 1,3,4,6,11.   
Numerous studies have demonstrated the desired 
fluid mobilization into the intravascular 
compartment (IVC) causing plasma volume 
expansion18,19,20,21.  Other effects due to HSS 
infusion include improved cardiac contractility, 
reduced blood viscosity, improved 
microcirculation and immunomodulation 20, 22.     
A study by Younes demonstrated a significantly 
higher 24 hour and 30 day survival for 
haemorrhagic shock patients given HSS than 
those on standard treatment 24,25.  A Cochrane 
Library review of 16 randomised trials involving 
837 patients concluded that the data was 
insufficient to decide whether HSS was better 
than isotonic crystalloids for resuscitation of 
trauma and burn patients, and for patients 
undergoing surgery 11.    
To date there has been no evidence demonstrated 
of clinical signs of hyperosmolality due to HSS 
infusion.  5,6,20,23,26,27. Following HSS infusion the 
raised serum osmolality starts dropping after 4-8 
hours, and is back to normal in 24 hours.  HSS 
infusion for resuscitation has become an 
established treatment of haemorrhagic shock in 
hospitals  in developed countries, and is being 
proposed for use in emergency rooms and 
ambulances.  In developing countries patients in 
need of resuscitation for hypovolemic shock are 
numerous, the cost of standard infusion fluids is 
high and the fluids are not readily available.  
Trauma victims and other patients in hypovolemic 
shock take much longer to reach hospital due to 
underdeveloped infrastructure.   There are 
therefore compelling reasons to advocate local 
studies of the use of HSS in resuscitation of 
patients in hypovolemic shock.    
Objectives 
The objective of the study was to document the 
immediate clinical outcomes in patients with 
haemorrhagic shock following resuscitation with 
locally made 7.5% hypertonic saline.   
Patients and Methods 
This was a hospital based descriptive study 
conducted at the Muhimbili Orthopaedic Institute 
(MOI) Casualty Department in Dar es Salaam, 
Tanzania.  The institute is the main centre for 
handling trauma cases in the city of 3.5 million 
inhabitants and is also a national trauma referral 
centre.  MOI houses the academic department of 
Orthopaedics and Traumatology of Muhimbili 
University College of Health Sciences.  Ethical 
clearance for the study was granted by the college 
ethical committee.    
During the six-month period, July 2005 to 
December 2005, all adult (age 14 to 70) trauma 
patients  diagnosed with haemorrhagic shock 
were enrolled into the study.  Using a statistical 
formula the sample size was calculated as 20 
patients.  Informed consent to be enrolled in the 
study was obtained from the patient or from a 
responsible relative in case of patients with 
impaired consciousness.  Patients were excluded 
from the study if they were pregnant, if they were 
on fluid infusion or blood transfusion before or on 
arrival, or if consent was not given.  A datasheet 
designed by the authors was used for patient 
information, which included identifying data, 
clinical findings, cause and class of shock, non-
invasive measurements of haemodynamic state, 
haematocrit, haemoglobin, serum electrolytes, 
serum creatinine, and survival 24 hours after 
resuscitation.  A clinical diagnosis of traumatic 
haemorrhagic shock was made if the patient with 
a history of traumatic haemorrhage had a systolic 
BP of 90mmHg or lower, mean arterial pressure 
(MAP) of 70mmHg or lower, a pulse rate of more 




than 0.5 mls/kg/hr.  A patient was considered to 
be recovering from shock if one or more of the 
following was documented:  SBP >90mmHg, 
MAP >70mmHg, pulse rate <100bpm, peripheral 
oxygen saturation >93%, and a urine output 
>0.5mls/kg/hr.   
A detailed clinical evaluation was performed.  
The airway was assessed and secured and 
oropharyngeal suction performed as indicated.  
The respiratory rate was recorded before and after 
HSS administration.  Circulatory assessment 
included a record of the pulse rate, heart rate, 
systolic blood pressure (SBP), diastolic blood 
pressure (DBP) and mean arterial pressure 
(MAP).  Five mls of blood was drawn from the 
anterior cubital vein before commencement of 
resuscitation for determination of haematocrit, 
haemoglobin, serum sodium, serum chloride, and 
serum creatinine.  Three to five minutes after HSS 
infusion, another sample of 5mls of blood was 
drawn from the contralateral vein.  In patients 
with injury involving the arms the blood was 
drawn form the femoral vein.  Blood was not 
drawn from the arm in which the HSS had been 
administered.  A urethral catheter was inserted for 
monitoring hourly urine output.  
The peripheral oxygen saturation was monitored 
continuously with the CSI Criticare 504 Dx 
digital pulse oxymeter. The SBP, DBP and MAP 
were measured with the CSI Criticare 506 N 
digital sphygmomanometer.  The pulse pressure 
was determined as the difference between SBP 
and DBP.  The first reading of the vital signs was 
taken before the HSS infusion and the second 3-5 
minutes after HSS infusion and before any 
additional fluid infusion.    
All casualty doctors were trained by the authors to 
comply with the study protocol on resuscitation of 
trauma patients before commencement of the 
study.  For resuscitation 250mls of 7.5% 
hypertonic saline per bottle, prepared at the 
hospital pharmacy was infused through a gauge 
16 cannula. Six patients had gauge 18 cannula 
because of difficult access with a gauge 16 
cannula. The 250mls of 7.5% HSS was 
administered over 2 to 4 minutes.   Patients who 
responded favourably to the HSS infusion were 
maintained on crystalline intravenous fluids.  
Those patients who after the initial infusion of 
HSS had SBP <90mmHg, MAP <70mmHg, with 
other clinical signs including tachycardia (pulse 
rate >100/min) were considered as not clinically 
responding to the HSS infusion. An infusion 
500mls NS or RL was commenced to run over 4-6 
minutes, repeated as required for the patient to 
respond to treatment of shock. Blood replacement 
was carried out when indicated. Meanwhile, 
preparation was made for surgery and other 
treatment for the patient’s clinical condition as 
indicated. Patients were reviewed by attending 
staff four hourly or more frequently as required. 
All patients were re-evaluated and findings 
documented at 24 hours after resuscitation.   The 
degree of shock was classified according to 
Modified Classification of Shock from the 
Committee of Trauma of the American College of 
Surgeons.  
The data were entered into a computer data base 
and analysed using SPSS version 12. Chi square 
test was used to compare proportions in 2x2 
tables, while Fisher’s exact test was used for cells 
with small numbers.  P value of < 0.05 was 
considered significant. Logistic regression was 
used to assess contribution of selected variables to 
survival beyond 24 hours after resuscitation.   
Results 
During the 6 month study period, a total of 1882 
adult trauma patients were attended at the MOI 
casualty. Out of these, 67 patients (3.6%) had 
hemorrhagic shock and were eligible for the 
study. Twenty-two (32.8%) died on admission or 
during assessment before commencement of 
resuscitation and were excluded from the analysis. 
The remaining 45 patients were enrolled and 
resuscitated with 250 mls 7.5% hypertonic saline. 
Among the studied patients 36 (80.0%) were 
males and 9 (20.0%) were females. The median 
age was 28 years. Of the 45 patients 37 (82.2%) 
had been involved in a motor traffic accident, six 
were injured in a human assault, one had bullet 
injury and one was injured in a fall from a height.  
Of the studied population 64.4% had a single 
injury of which three quarters were visceral 
injuries. Sixty per cent of the patients had shock 
class III while 15.6% had class II and 24.4% had 







Table 1. Characteristics of patients who underwent resuscitation using HSS. 
Variable Frequency (n = 45) Perentage 
 
   
Age (Years)   
<45 41 91.1 
45 and Above 4 8.9 
Median 28  
   
Sex   
Male 36 80 
Female 9 20 
   
Mechanism of Injury   
Motor traffic Accident 37 82.2 
Assault 6 13.3 
Fall 1 2.2 
Bullet Injury 1 2.2 
   
Diagnosis   
Single Injury 29 64.4 
Multiple injuries 16 35.6 
   
Class of Shock   
II 7 15.6 
III 27 60.0 
IV 11 24.4 
   
GCS   
<8 6 13.3 
9-12 4 8.9 
13-15 35 77.8 
Median  15  
   
 
Table 2. Glasgow Coma Score (GCS) of the patients before and after treatment  
 
Level of Consciousness (GCS) Pre-treatment Frequency (%)   Post-treatment Frequency (%) 
 
5-8 6         (13.3%)   4           (8.9%)  
9-12 4          (8.9%)  3            (6.7%) 
13-15 35         (77.8%) 38         (84.4%) 
Total 45        (100%) 45        (100%) 
 
Thirty-five patients (77.8%) had either no signs of 
head injury or a mild degree of head injury, the 
median Glasgow Coma score (GCS) being 15.  
Table 1 summarizes the characteristics of the 
study population. The SBP, DBP, MAP, and 
arterial oxygen saturation (SaO2) on admission 
were below normal in all patients. The mean rise 
of each after resuscitation was 38.30± 12.75, 
24.04 ± 11.00, 25.96± 10.08 and 7.64% ± 6.95 
respectively, and the change was statistically  
 
significant (p< 0.001). The pulse and heart rate 
dropped significantly by 25.89±8.65 and 
26.02±9.30 respectively, a change that was 
statistically significant, p<0.001 
On admission, the serum levels of sodium and 
chloride were within the normal range. Serum 
sodium concentration ranged from 130 –
145mmols/L with a mean concentration of 140.00 




111 mmol/L with a mean concentration of 106.22 
± 3.40 mmol/L. After resuscitation, all patients 
had an increase in serum sodium and chloride 
concentration with mean rise of 10.96mmol/L and 
10.91mmol/L respectively. The increase was 
statistically significant (p<0.001). Haemoglobin 
and Haematocrit dropped significantly by mean 
drop of 1.51g/dL and 4.42% respectively 
(p<0.001).  
 
Table 3. Association between age, level of consciousness, type of injury and class of shock with clinical 
recovery from shock. 
Variable N = 45 Recovered Not recovered Total P- value 
 
     
Age      
<45 years 38 (92.7%) 3 (7.3%) 41 0.055 
45+ and Above 2 (20.0%) 2 (50%) 4  
     
GCS     
5-8 5 (83.3%) 1 (16.7%) 6  
9-12 3 (75%) 1 (25%) 4  
13-15 32 (91.4%) 3 (8.6%) 35 0.743 
     
Diagnosis     
Visceral Injury 28  (96.6%) 1 (3.4%) 29  
Multiple Injuries 12 (75.0%) 4 (25%) 16 0.047 
     
Class of Shock      
 III 33 (97.1%) 1 (2.9%) 34  
IV 7 (63.3%) 4 (36.4%) 11 0.010 
Table 4. Age, Level of Consciousness, Type of Injury And Class of Shock to Survival Beyond 24 Hours. 
Variable (n=45) Survived Died Total p-value 
     
Age     
<45 years 35 (85.4%) 6 (14.6%) 41  
45+ 1 (25.0%) 3 (75.0%) 4 0.021 
     
GCS     
5-8 3 (50.0%) 3 (50.0%) 6  
9-12 4 (100%) 0  (0.0%) 4  
13-15 29 (82.9%) 6 (17.1%) 35 0.075 
     
Diagnosis     
Single Injury 27 (93.1%) 2 (6.9%) 29  
Multiple Injuries 9 (56.3%) 7 (43.5%) 16  
    0.006 
Class of shock     
 III 30 (88.2%) 4 (11.8%) 34  
IV 6 (54.5%) 5 (45.5%) 11 0.028 
     
MAP      
 65mmHg 31 (79.5%) 8 (20.5%) 39  
65mmHg + 5 (83.3%) 1 (16.7%) 6 1.000 




Table 5.  Correlation between Survival Beyond 24 Hours with Selected Variables.  
Exposure variables Odds ratio 95% CI P value 
 
    










    








    









    
 
The level of consciousness improved after 
resuscitation with 7.5% HSS (Table 2). Among 
the studied patients, 88.9% recovered from shock 
immediately after being infused with 7.5% HSS. 
The proportion of those who recovered decreased 
with decrease in neither level of consciousness 
but neither age nor level of consciousness was 
statistically significantly associated with clinical 
recovery from shock.  
Of patients with a single injury, 96.6% recovered 
from shock whereas only 75% of those with 
multiple injuries recovered (p=0.047). Of patients 
with class II or III shock, 97.1% recovered from 
shock while only 63.3% of those with class IV 
recovered. This difference was statistically 
significant, p=0.01. (Table 3)   
Eighty percent of patients survived beyond 24 
hours post resuscitation. Only 56.3% of those 
who sustained multiple injuries, survived beyond 
24 hours while among those who had single 
injury, 93.1% survived beyond 24 hours. ( p = 
0.006). The proportion of those with a severe 
form of shock (class IV) who survived beyond 24 
hours was much lower than that of those with a 
lower class of shock. (p = 0.028) There was no 
association between the MAP, level of 
consciousness on admission with survival beyond 
24 hours post resuscitation, p = 1.000 (Table 4)  
With logistic regression of baseline admission 
variables, age, type of injury and class of shock 
sustained were not predictors of survival beyond 
24 hours after resuscitation. (Table 5) 
 
 Discussion 
This study has demonstrated short term clinical 
benefits following administration of 7.5% 
hypertonic saline solution in patients with 
hemorrhagic shock. No adverse effects on 
homeostasis or haemodynamics were found.  The 
goal of treatment of shock is to restore tissue 
perfusion and oxygen delivery. HSS infusion 
effects a rapid increase of blood volume, 
improves cardiac output, raises the blood pressure 
and therefore improves tissue perfusion.5,6,7.  The 
restoration of intravascular volume occurs at the 
expense of the intracellular volume compartment, 
therefore administration of regular intravenous 
fluid, and blood if required, should follow so as to 
eventually restore a normal fluid balance9.  In the 
present study, rapid infusion of HSS caused a 
significant rise in systolic, diastolic and mean 
arterial pressure toward normal with a mean 
change of 38.30± 12.75, 24.04 ±11.00, 25.96 
±10.8, respectively (p<0.001). A rise in blood 
pressure improves cardiac output, which therefore 
improves tissue perfusion. The pulse and heart 
rate dropped significantly by 25.89±8.65 and 
26.02±9.30 respectively.  The patients had a sub 
optimal peripheral oxygen saturation before, 
which improved after resuscitation with a mean 
rise of 7.64 % ± 6.95, a rise which was 
statistically significant (p<0.001).   
HSS contains sodium and chloride at a 
concentration of 1,280 mmol/l. This is equivalent 
to nine times the normal serum sodium and 12 
times the normal chloride concentration. 
Consequently, alterations of these serum 




given special attention in early studies to see if it 
would lead to complications.   
In the current series the only reported adverse 
effect was pain at the infusion site, documented in 
5 patients (14.3%), all of whom had a change 
from gauge 16 to gauge 18 cannula. This may 
have been due to extravasation of the hypertonic 
fluid into surrounding tissue. Infusion site pain 
has not been reported in other studies. Of the 
numerous studies that have been carried out none 
has reported any clinical sign of 
hyperosmolarity5,6,7,20,23. A few minor adverse 
effects, including restlessness, voiding urge, poor 
taste and vomiting were reported in one study 20. 
They were more suggestive of reaction to very 
rapid infusion than to the temporary 
hyperosmolarity. No neuropathological signs 
were reported secondary to the relative 
hypernatremia. For patients who had an infusion 
of HSS and did not survive, autopsy done showed 
no evidence of central pontine myelinosis20.  In 
this study the mean serum sodium and chloride 
levels 5 minutes after HSS infusion was 151.91 ± 
3.42 and 117.22 ± 4.27 respectively. Similar 
results were reported in previous studies. 6,20, 
23,26,27  
More than 85% of the patients recovered from 
shock within the first five minutes after 
resuscitation with 250mls of HSS. More than 90% 
of the studied patients had an emergency 
operation soon after resuscitation.  
The short time required for infusion and the small 
amount of infusion (250mls of 7.5% HSS) to 
optimize these patients before anaesthesia is a 
great advantage in situations where life-saving 
surgery is urgently required and blood for urgent 
transfusion is not readily available.  To attain the 
same degree of intravascular volume restoration 
with crystalloids would take close to 3 litres and a 
correspondingly long time to administer it.  
Eighty percent of the studied patients survived the 
first 24 hours. Different studies on HSS 
resuscitation have looked at its efficacy in 
improving survival by evaluating 24 hours and 
long-term survival. In these studies 24 hour 
survival rate was significantly higher in trauma 
patients who had an infusion of HSS as compared 
to isotonic saline. The survival rate ranged from 
82.5% to 87.5%4, 7, 24, 25.  
In conclusion, to the authors’ knowledge, this is 
the first study on small volume resuscitation in 
the East African region. It has demonstrated 
clinical benefits in initial treatment of traumatic 
hemorrhagic shock in patients admitted to the 
emergency room.  The findings also indicate that 
side effects following small volume resuscitation 
with HSS are rare and generally without serious 
consequence.  Small volume resuscitation with 
HSS is safe and effective.  Clinical trials 
comparing the beneficial effects of HSS 
resuscitation with conventional isotonic fluids in 
the local setting are warranted.  
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